PREPL, a prolyl endopeptidase-like enzyme by name only? - lessons from patients

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 3, 2011, Pages 355-360

  Boonen, Kurt ^a   Régal, Luc ^a,b   Jaeken, Jaak ^b   Creemers, John W M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

2p21 deletion syndrome; HCS; Oligopeptidase; Prader willi syndrome; Propeller; Proteolytic; SLC3A1

Indexed keywords

PROLYL ENDOPEPTIDASE; SODIUM PHOSPHATE COTRANSPORTER 2A;

ARTICLE; CYSTINURIA; GENE; GENE DELETION; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; MUSCLE HYPOTONIA; NEPHROLITHIASIS; NOMENCLATURE; NONHUMAN; PRADER WILLI SYNDROME; PROLYL ENDOPEPTIDASE LIKE GENE; SEQUENCE HOMOLOGY;

EID: 79951715223     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152711794653760     Document Type: Article

References (28)

1. Martens, K.; Jaeken, J.; Matthijs, G.; Creemers, J.W. Multi-system disorder syndromes associated with cystinuria type I. Curr. Mol. Med., 2008, 8, 544-550.
2. Parvari, R.; Hershkovitz, E. Chromosomal microdeletions and genes' functions: a cluster of chromosomal microdeletions and the deleted genes' functions. Eur. J. Hum. Genet., 2007, 15, 997-998.
3. Goodyer, P. The molecular basis of cystinuria. Nephron Exp. Nephrol., 2004, 98, e45-e49.
4. Dello, S.L.; Pras, E.; Pontesilli, C.; Beccia, E.; Ricci-Barbini, V.; de Sanctis, L.; Ponzone, A.; Gallucci, M.; Bisceglia, L.; Zelante, L.; Jimenez-Vidal, M.; Font, M.; Zorzano, A.; Rousaud, F.; Nunes, V.; Gasparini, P.; Palacín, M.; Rizzoni, G. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J. Am. Soc. Nephrol., 2002, 13, 2547-2553.
5. Clara, R.; Lowenthal, A. Familial aminoaciduria with muscular hypotonia and dwarfism. Bull. Acad. R. Med. Belg., 1966, 6, 577-611.
6. Jaeken, J.; Martens, K.; Francois, I.; Eyskens, F.; Lecointre, C.; Derua, R.; Meulemans, S.; Slootstra, J.W.; Waelkens, E.; de Zegher, F.; Creemers, J.W.; Matthijs, G. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am. J. Hum. Genet., 2006, 78, 38-51.
7. Allen Mouse Brain Atlas. http,//mouse.brain-map.org/
8. Cassidy, S.B.; Driscoll, D.J.; Prader-Willi syndrome. Eur. J. Hum. Genet., 2009, 17, 3-13.
9. Martens, K.; Heulens, I.; Meulemans, S.; Zaffanello, M.; Tilstra, D.; Hes, F.J.; Rooman, R.; Francois, I.; de Zegher, F.; Jaeken, J.; Matthijs, G.; Creemers, J.W. Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome. Eur. J. Hum. Genet., 2007, 15, 1029-1033.
10. Chabrol, B.; Martens, K.; Meulemans, S.; Cano, A.; Jaeken, J.; Matthijs, G.; Creemers, J.W. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. J. Med. Genet., 2008, 45, 314-318.
11. Pintard, L.; Kressler, D.; Lapeyre, B. Spb1p is a yeast nucleolar protein associated with Nop1p and Nop58p that is able to bind Sadenosyl- L-methionine in vitro. Mol. Cell Biol., 2000, 20, 1370-1381.
12. Huang, C.C.; Chang, W.S. Cooperation between NRF-2 and YY-1 transcription factors is essential for triggering the expression of the PREPL-C2ORF34 bidirectional gene pair. BMC Mol. Biol., 2009, 10, 67.
13. Parvari, R.; Brodyansky, I.; Elpeleg, O.; Moses, S.; Landau, D.; Hershkovitz, E. A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am. J. Hum. Genet., 2001, 69, 869-875.
14. Parvari, R.; Gonen, Y.; Alshafee, I.; Buriakovsky, S.; Regev, K.; Hershkovitz, E. The 2p21 deletion syndrome, characterization of the transcription content. Genomics, 2005, 86, 195-211.
15. Klumpp, S.; Thissen, M.C.; Krieglstein, J. Protein phosphatases types 2Calpha and 2Cbeta in apoptosis. Biochem. Soc. Trans., 2006, 34, 1370-1375.
16. Sasaki, M.; Ohnishi, M.; Tashiro, F.; Niwa, H.; Suzuki, A.; Miyazaki, J.; Kobayashi, T.; Tamura, S. Disruption of the mouse protein Ser/Thr phosphatase 2Cbeta gene leads to early preimplantation lethality. Mech. Dev., 2007, 124, 489-499.
17. Garcia-Horsman, J.A.; Mannisto, P.T.; Venalainen, J.I. On the role of prolyl oligopeptidase in health and disease. Neuropeptides, 2007, 41, 1-24.
18. Coetzer, T.H.; Goldring, J.P.; Huson, L.E. Oligopeptidase B, a processing peptidase involved in pathogenesis. Biochimie, 2008, 90, 336-344.
19. Fulop, V.; Bocskei, Z.; Polgar, L. Prolyl oligopeptidase, an unusual beta-propeller domain regulates proteolysis. Cell, 1998, 94, 161-170.
20. Hotelier, T.; Renault, L.; Cousin, X.; Negre, V.; Marchot, P.; Chatonnet, A. ESTHER: the database of the alpha/beta-hydrolase fold superfamily of proteins. Nucleic Acids Res., 2004, 32, D145-D147.
21. Szeltner, Z.; Alshafee, I.; Juhasz, T.; Parvari, R.; Polgar, L. The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity. Cell Mol. Life Sci., 2005, 62, 2376-2381.
22. Martens, K.; Derua, R.; Meulemans, S.; Waelkens, E.; Jaeken, J.; Matthijs, G.; Creemers, J.W. PREPL, a putative novel oligopeptidase propelled into the limelight. Biol. Chem., 2006, 387, 879-883.
23. Di Daniel, E.; Glover, C.P.; Grot, E.; Chan, M.K.; Sanderson, T.H.; White, J.H.; Ellis, C.L.; Gallagher, K.T.; Uney, J.; Thomas, J.; Maycox, P.R.; Mudge, A.W. Prolyl oligopeptidase binds to GAP- 43 and functions without its peptidase activity. Mol. Cell Neurosci., 2009, 41, 373-382.
24. Schulz, I.; Gerhartz, B.; Neubauer, A.; Holloschi, A.; Heiser, U.; Hafner, M.; Demuth, H.U. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur. J. Biochem., 2002, 269, 5813-5820.
25. Williams, R.S.; Cheng, L.; Mudge, A.W.; Harwood, A.J. A common mechanism of action for three mood-stabilizing drugs. Nature, 2002, 417, 292-295.
26. Williams, R.S.; Eames, M.; Ryves, W.J.; Viggars, J.; Harwood, A.J. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J., 1999, 18, 2734-2745.
27. Oldham, M.C.; Konopka, G.; Iwamoto, K.; Langfelder, P.; Kato, T.; Horvath, S.; Geschwind, D.H. Functional organization of the transcriptome in human brain. Nat. Neurosci., 2008, 11, 1271-1282.
28. Asadollahi, R.; Bartholdi, D.; Oneda, B.; Baumer, A.; Rauch, A. Partial, homozygous deletion of PREPL and C2orf34 on 2p21 in siblings with atypical hypotonia-cystinuria syndrome. International Conference on Genetics and Neurobiology of Mental Retardation. Erlangen, Germany, 2010.